nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—lung cancer—melanoma	0.52	1	CtDrD
Topotecan—ABCB1—melanoma	0.119	1	CbGaD
Topotecan—ABCG2—Vemurafenib—melanoma	0.0802	0.327	CbGbCtD
Topotecan—ABCG2—Dactinomycin—melanoma	0.0533	0.217	CbGbCtD
Topotecan—CYP3A4—Temozolomide—melanoma	0.0316	0.129	CbGbCtD
Topotecan—ABCG2—Docetaxel—melanoma	0.0275	0.112	CbGbCtD
Topotecan—ABCB1—Dactinomycin—melanoma	0.0192	0.0784	CbGbCtD
Topotecan—CYP3A4—Vemurafenib—melanoma	0.0173	0.0707	CbGbCtD
Topotecan—ABCB1—Docetaxel—melanoma	0.00992	0.0405	CbGbCtD
Topotecan—CYP3A4—Docetaxel—melanoma	0.00594	0.0243	CbGbCtD
Topotecan—Irinotecan—ALB—melanoma	0.00051	0.512	CrCbGaD
Topotecan—Irinotecan—ABCB1—melanoma	0.000487	0.488	CrCbGaD
Topotecan—Pneumonia—Bleomycin—melanoma	0.000278	0.00318	CcSEcCtD
Topotecan—Pulmonary embolism—Docetaxel—melanoma	0.000277	0.00317	CcSEcCtD
Topotecan—Pancytopenia—Dactinomycin—melanoma	0.000274	0.00314	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000272	0.00311	CcSEcCtD
Topotecan—Neutropenia—Dactinomycin—melanoma	0.00027	0.00309	CcSEcCtD
Topotecan—Stomatitis—Bleomycin—melanoma	0.000269	0.00308	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Temozolomide—melanoma	0.000266	0.00305	CcSEcCtD
Topotecan—Colitis—Docetaxel—melanoma	0.000266	0.00304	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000265	0.00303	CcSEcCtD
Topotecan—Neuropathy—Docetaxel—melanoma	0.00026	0.00297	CcSEcCtD
Topotecan—Pneumonia—Dactinomycin—melanoma	0.000259	0.00296	CcSEcCtD
Topotecan—Pancytopenia—Carmustine—melanoma	0.000257	0.00294	CcSEcCtD
Topotecan—Neutropenia—Carmustine—melanoma	0.000253	0.00289	CcSEcCtD
Topotecan—Decreased appetite—Vemurafenib—melanoma	0.000253	0.00289	CcSEcCtD
Topotecan—Stomatitis—Dactinomycin—melanoma	0.000251	0.00287	CcSEcCtD
Topotecan—Gastrointestinal disorder—Vemurafenib—melanoma	0.000251	0.00287	CcSEcCtD
Topotecan—Fatigue—Vemurafenib—melanoma	0.000251	0.00287	CcSEcCtD
Topotecan—Neoplasm—Docetaxel—melanoma	0.00025	0.00286	CcSEcCtD
Topotecan—Haemoglobin—Bleomycin—melanoma	0.000249	0.00285	CcSEcCtD
Topotecan—Constipation—Vemurafenib—melanoma	0.000248	0.00284	CcSEcCtD
Topotecan—Pancytopenia—Temozolomide—melanoma	0.000248	0.00284	CcSEcCtD
Topotecan—Haemorrhage—Bleomycin—melanoma	0.000248	0.00284	CcSEcCtD
Topotecan—Hypoaesthesia—Bleomycin—melanoma	0.000247	0.00282	CcSEcCtD
Topotecan—Neutropenia—Temozolomide—melanoma	0.000244	0.00279	CcSEcCtD
Topotecan—Pneumonia—Carmustine—melanoma	0.000242	0.00277	CcSEcCtD
Topotecan—Sepsis—Docetaxel—melanoma	0.00024	0.00275	CcSEcCtD
Topotecan—Weight increased—Temozolomide—melanoma	0.000238	0.00272	CcSEcCtD
Topotecan—Neuropathy peripheral—Carmustine—melanoma	0.000236	0.0027	CcSEcCtD
Topotecan—Stomatitis—Carmustine—melanoma	0.000235	0.00269	CcSEcCtD
Topotecan—Pneumonia—Temozolomide—melanoma	0.000234	0.00268	CcSEcCtD
Topotecan—Infestation—Temozolomide—melanoma	0.000233	0.00266	CcSEcCtD
Topotecan—Infestation NOS—Temozolomide—melanoma	0.000233	0.00266	CcSEcCtD
Topotecan—Body temperature increased—Vemurafenib—melanoma	0.00023	0.00263	CcSEcCtD
Topotecan—Pharyngitis—Dactinomycin—melanoma	0.000229	0.00262	CcSEcCtD
Topotecan—Neuropathy peripheral—Temozolomide—melanoma	0.000228	0.00261	CcSEcCtD
Topotecan—Stomatitis—Temozolomide—melanoma	0.000227	0.0026	CcSEcCtD
Topotecan—Chills—Bleomycin—melanoma	0.000222	0.00254	CcSEcCtD
Topotecan—Hepatobiliary disease—Temozolomide—melanoma	0.00022	0.00252	CcSEcCtD
Topotecan—Alopecia—Bleomycin—melanoma	0.000219	0.00251	CcSEcCtD
Topotecan—Haemoglobin—Carmustine—melanoma	0.000217	0.00249	CcSEcCtD
Topotecan—Haemorrhage—Carmustine—melanoma	0.000216	0.00247	CcSEcCtD
Topotecan—Hypoaesthesia—Carmustine—melanoma	0.000215	0.00246	CcSEcCtD
Topotecan—Hypersensitivity—Vemurafenib—melanoma	0.000214	0.00245	CcSEcCtD
Topotecan—Dermatitis bullous—Docetaxel—melanoma	0.00021	0.00241	CcSEcCtD
Topotecan—Haemoglobin—Temozolomide—melanoma	0.00021	0.0024	CcSEcCtD
Topotecan—Haemorrhage—Temozolomide—melanoma	0.000209	0.00239	CcSEcCtD
Topotecan—Asthenia—Vemurafenib—melanoma	0.000208	0.00239	CcSEcCtD
Topotecan—Hypoaesthesia—Temozolomide—melanoma	0.000208	0.00238	CcSEcCtD
Topotecan—Pharyngitis—Temozolomide—melanoma	0.000207	0.00237	CcSEcCtD
Topotecan—Chills—Dactinomycin—melanoma	0.000207	0.00237	CcSEcCtD
Topotecan—Pruritus—Vemurafenib—melanoma	0.000206	0.00235	CcSEcCtD
Topotecan—Lethargy—Docetaxel—melanoma	0.000205	0.00235	CcSEcCtD
Topotecan—Alopecia—Dactinomycin—melanoma	0.000204	0.00234	CcSEcCtD
Topotecan—Ill-defined disorder—Bleomycin—melanoma	0.0002	0.00229	CcSEcCtD
Topotecan—Anaemia—Bleomycin—melanoma	0.000199	0.00228	CcSEcCtD
Topotecan—Diarrhoea—Vemurafenib—melanoma	0.000199	0.00227	CcSEcCtD
Topotecan—Malaise—Bleomycin—melanoma	0.000195	0.00223	CcSEcCtD
Topotecan—Leukopenia—Bleomycin—melanoma	0.000193	0.00221	CcSEcCtD
Topotecan—Dizziness—Vemurafenib—melanoma	0.000192	0.0022	CcSEcCtD
Topotecan—Alopecia—Carmustine—melanoma	0.000191	0.00219	CcSEcCtD
Topotecan—Angiopathy—Temozolomide—melanoma	0.00019	0.00217	CcSEcCtD
Topotecan—Immune system disorder—Temozolomide—melanoma	0.000189	0.00216	CcSEcCtD
Topotecan—Mediastinal disorder—Temozolomide—melanoma	0.000188	0.00216	CcSEcCtD
Topotecan—Malnutrition—Carmustine—melanoma	0.000188	0.00215	CcSEcCtD
Topotecan—Cough—Bleomycin—melanoma	0.000188	0.00215	CcSEcCtD
Topotecan—Chills—Temozolomide—melanoma	0.000188	0.00215	CcSEcCtD
Topotecan—Ill-defined disorder—Dactinomycin—melanoma	0.000187	0.00214	CcSEcCtD
Topotecan—Anaemia—Dactinomycin—melanoma	0.000186	0.00213	CcSEcCtD
Topotecan—Vomiting—Vemurafenib—melanoma	0.000185	0.00211	CcSEcCtD
Topotecan—Alopecia—Temozolomide—melanoma	0.000185	0.00211	CcSEcCtD
Topotecan—Chest pain—Bleomycin—melanoma	0.000184	0.0021	CcSEcCtD
Topotecan—Myalgia—Bleomycin—melanoma	0.000184	0.0021	CcSEcCtD
Topotecan—Rash—Vemurafenib—melanoma	0.000183	0.0021	CcSEcCtD
Topotecan—Dermatitis—Vemurafenib—melanoma	0.000183	0.00209	CcSEcCtD
Topotecan—Back pain—Carmustine—melanoma	0.000182	0.00208	CcSEcCtD
Topotecan—Headache—Vemurafenib—melanoma	0.000182	0.00208	CcSEcCtD
Topotecan—Malnutrition—Temozolomide—melanoma	0.000182	0.00208	CcSEcCtD
Topotecan—Discomfort—Bleomycin—melanoma	0.000181	0.00208	CcSEcCtD
Topotecan—Malaise—Dactinomycin—melanoma	0.000181	0.00208	CcSEcCtD
Topotecan—Cramp muscle—Docetaxel—melanoma	0.000181	0.00207	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000181	0.00207	CcSEcCtD
Topotecan—Leukopenia—Dactinomycin—melanoma	0.00018	0.00206	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Docetaxel—melanoma	0.000177	0.00203	CcSEcCtD
Topotecan—Anaphylactic shock—Bleomycin—melanoma	0.000176	0.00201	CcSEcCtD
Topotecan—Back pain—Temozolomide—melanoma	0.000176	0.00201	CcSEcCtD
Topotecan—Infection—Bleomycin—melanoma	0.000175	0.002	CcSEcCtD
Topotecan—Anaemia—Carmustine—melanoma	0.000174	0.00199	CcSEcCtD
Topotecan—Nausea—Vemurafenib—melanoma	0.000173	0.00197	CcSEcCtD
Topotecan—Thrombocytopenia—Bleomycin—melanoma	0.000172	0.00197	CcSEcCtD
Topotecan—Myalgia—Dactinomycin—melanoma	0.000171	0.00196	CcSEcCtD
Topotecan—Discomfort—Dactinomycin—melanoma	0.000169	0.00194	CcSEcCtD
Topotecan—Ill-defined disorder—Temozolomide—melanoma	0.000169	0.00193	CcSEcCtD
Topotecan—Leukopenia—Carmustine—melanoma	0.000169	0.00193	CcSEcCtD
Topotecan—Anaemia—Temozolomide—melanoma	0.000168	0.00192	CcSEcCtD
Topotecan—Anorexia—Bleomycin—melanoma	0.000168	0.00192	CcSEcCtD
Topotecan—Angioedema—Temozolomide—melanoma	0.000166	0.0019	CcSEcCtD
Topotecan—Pancytopenia—Docetaxel—melanoma	0.000165	0.00189	CcSEcCtD
Topotecan—Malaise—Temozolomide—melanoma	0.000164	0.00188	CcSEcCtD
Topotecan—Infection—Dactinomycin—melanoma	0.000163	0.00187	CcSEcCtD
Topotecan—Leukopenia—Temozolomide—melanoma	0.000163	0.00186	CcSEcCtD
Topotecan—Neutropenia—Docetaxel—melanoma	0.000162	0.00186	CcSEcCtD
Topotecan—Thrombocytopenia—Dactinomycin—melanoma	0.000161	0.00184	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Bleomycin—melanoma	0.00016	0.00184	CcSEcCtD
Topotecan—Myalgia—Carmustine—melanoma	0.00016	0.00183	CcSEcCtD
Topotecan—Chest pain—Carmustine—melanoma	0.00016	0.00183	CcSEcCtD
Topotecan—Cough—Temozolomide—melanoma	0.000159	0.00182	CcSEcCtD
Topotecan—Paraesthesia—Bleomycin—melanoma	0.000158	0.00181	CcSEcCtD
Topotecan—Weight increased—Docetaxel—melanoma	0.000158	0.00181	CcSEcCtD
Topotecan—Dyspnoea—Bleomycin—melanoma	0.000157	0.0018	CcSEcCtD
Topotecan—Anorexia—Dactinomycin—melanoma	0.000157	0.00179	CcSEcCtD
Topotecan—Pneumonia—Docetaxel—melanoma	0.000156	0.00178	CcSEcCtD
Topotecan—Arthralgia—Temozolomide—melanoma	0.000155	0.00177	CcSEcCtD
Topotecan—Myalgia—Temozolomide—melanoma	0.000155	0.00177	CcSEcCtD
Topotecan—Infestation NOS—Docetaxel—melanoma	0.000155	0.00177	CcSEcCtD
Topotecan—Infestation—Docetaxel—melanoma	0.000155	0.00177	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000154	0.00176	CcSEcCtD
Topotecan—Discomfort—Temozolomide—melanoma	0.000153	0.00175	CcSEcCtD
Topotecan—Decreased appetite—Bleomycin—melanoma	0.000153	0.00175	CcSEcCtD
Topotecan—Infection—Carmustine—melanoma	0.000153	0.00175	CcSEcCtD
Topotecan—Neuropathy peripheral—Docetaxel—melanoma	0.000152	0.00174	CcSEcCtD
Topotecan—Stomatitis—Docetaxel—melanoma	0.000151	0.00173	CcSEcCtD
Topotecan—Pain—Bleomycin—melanoma	0.000151	0.00172	CcSEcCtD
Topotecan—Thrombocytopenia—Carmustine—melanoma	0.00015	0.00172	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00015	0.00171	CcSEcCtD
Topotecan—Anaphylactic shock—Temozolomide—melanoma	0.000149	0.0017	CcSEcCtD
Topotecan—Infection—Temozolomide—melanoma	0.000148	0.00169	CcSEcCtD
Topotecan—Anorexia—Carmustine—melanoma	0.000146	0.00168	CcSEcCtD
Topotecan—Hepatobiliary disease—Docetaxel—melanoma	0.000146	0.00168	CcSEcCtD
Topotecan—Epistaxis—Docetaxel—melanoma	0.000146	0.00167	CcSEcCtD
Topotecan—Nervous system disorder—Temozolomide—melanoma	0.000146	0.00167	CcSEcCtD
Topotecan—Thrombocytopenia—Temozolomide—melanoma	0.000145	0.00166	CcSEcCtD
Topotecan—Feeling abnormal—Bleomycin—melanoma	0.000145	0.00166	CcSEcCtD
Topotecan—Skin disorder—Temozolomide—melanoma	0.000144	0.00165	CcSEcCtD
Topotecan—Hyperhidrosis—Temozolomide—melanoma	0.000144	0.00164	CcSEcCtD
Topotecan—Decreased appetite—Dactinomycin—melanoma	0.000143	0.00163	CcSEcCtD
Topotecan—Fatigue—Dactinomycin—melanoma	0.000142	0.00162	CcSEcCtD
Topotecan—Anorexia—Temozolomide—melanoma	0.000142	0.00162	CcSEcCtD
Topotecan—Pain—Dactinomycin—melanoma	0.00014	0.00161	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Carmustine—melanoma	0.00014	0.0016	CcSEcCtD
Topotecan—Urticaria—Bleomycin—melanoma	0.00014	0.0016	CcSEcCtD
Topotecan—Haemoglobin—Docetaxel—melanoma	0.00014	0.0016	CcSEcCtD
Topotecan—Rhinitis—Docetaxel—melanoma	0.000139	0.00159	CcSEcCtD
Topotecan—Body temperature increased—Bleomycin—melanoma	0.000139	0.00159	CcSEcCtD
Topotecan—Haemorrhage—Docetaxel—melanoma	0.000139	0.00159	CcSEcCtD
Topotecan—Hypoaesthesia—Docetaxel—melanoma	0.000138	0.00158	CcSEcCtD
Topotecan—Paraesthesia—Carmustine—melanoma	0.000138	0.00158	CcSEcCtD
Topotecan—Pharyngitis—Docetaxel—melanoma	0.000138	0.00158	CcSEcCtD
Topotecan—Dyspnoea—Carmustine—melanoma	0.000137	0.00157	CcSEcCtD
Topotecan—Feeling abnormal—Dactinomycin—melanoma	0.000135	0.00155	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Temozolomide—melanoma	0.000135	0.00155	CcSEcCtD
Topotecan—Gastrointestinal pain—Dactinomycin—melanoma	0.000134	0.00154	CcSEcCtD
Topotecan—Decreased appetite—Carmustine—melanoma	0.000134	0.00153	CcSEcCtD
Topotecan—Paraesthesia—Temozolomide—melanoma	0.000133	0.00153	CcSEcCtD
Topotecan—Gastrointestinal disorder—Carmustine—melanoma	0.000133	0.00152	CcSEcCtD
Topotecan—Dyspnoea—Temozolomide—melanoma	0.000132	0.00151	CcSEcCtD
Topotecan—Constipation—Carmustine—melanoma	0.000131	0.0015	CcSEcCtD
Topotecan—Pain—Carmustine—melanoma	0.000131	0.0015	CcSEcCtD
Topotecan—Dyspepsia—Temozolomide—melanoma	0.000131	0.0015	CcSEcCtD
Topotecan—Abdominal pain—Dactinomycin—melanoma	0.00013	0.00149	CcSEcCtD
Topotecan—Body temperature increased—Dactinomycin—melanoma	0.00013	0.00149	CcSEcCtD
Topotecan—Hypersensitivity—Bleomycin—melanoma	0.00013	0.00148	CcSEcCtD
Topotecan—Decreased appetite—Temozolomide—melanoma	0.000129	0.00148	CcSEcCtD
Topotecan—Gastrointestinal disorder—Temozolomide—melanoma	0.000128	0.00147	CcSEcCtD
Topotecan—Fatigue—Temozolomide—melanoma	0.000128	0.00146	CcSEcCtD
Topotecan—Pain—Temozolomide—melanoma	0.000127	0.00145	CcSEcCtD
Topotecan—Constipation—Temozolomide—melanoma	0.000127	0.00145	CcSEcCtD
Topotecan—Feeling abnormal—Carmustine—melanoma	0.000127	0.00145	CcSEcCtD
Topotecan—Asthenia—Bleomycin—melanoma	0.000126	0.00145	CcSEcCtD
Topotecan—Angiopathy—Docetaxel—melanoma	0.000126	0.00144	CcSEcCtD
Topotecan—Gastrointestinal pain—Carmustine—melanoma	0.000126	0.00144	CcSEcCtD
Topotecan—Immune system disorder—Docetaxel—melanoma	0.000126	0.00144	CcSEcCtD
Topotecan—Mediastinal disorder—Docetaxel—melanoma	0.000125	0.00143	CcSEcCtD
Topotecan—Chills—Docetaxel—melanoma	0.000125	0.00143	CcSEcCtD
Topotecan—Pruritus—Bleomycin—melanoma	0.000125	0.00143	CcSEcCtD
Topotecan—Alopecia—Docetaxel—melanoma	0.000123	0.00141	CcSEcCtD
Topotecan—Feeling abnormal—Temozolomide—melanoma	0.000122	0.0014	CcSEcCtD
Topotecan—Abdominal pain—Carmustine—melanoma	0.000121	0.00139	CcSEcCtD
Topotecan—Body temperature increased—Carmustine—melanoma	0.000121	0.00139	CcSEcCtD
Topotecan—Gastrointestinal pain—Temozolomide—melanoma	0.000121	0.00139	CcSEcCtD
Topotecan—Malnutrition—Docetaxel—melanoma	0.000121	0.00138	CcSEcCtD
Topotecan—Hypersensitivity—Dactinomycin—melanoma	0.000121	0.00138	CcSEcCtD
Topotecan—Urticaria—Temozolomide—melanoma	0.000118	0.00135	CcSEcCtD
Topotecan—Asthenia—Dactinomycin—melanoma	0.000118	0.00135	CcSEcCtD
Topotecan—Abdominal pain—Temozolomide—melanoma	0.000117	0.00134	CcSEcCtD
Topotecan—Body temperature increased—Temozolomide—melanoma	0.000117	0.00134	CcSEcCtD
Topotecan—Back pain—Docetaxel—melanoma	0.000117	0.00134	CcSEcCtD
Topotecan—Muscle spasms—Docetaxel—melanoma	0.000116	0.00133	CcSEcCtD
Topotecan—Hypersensitivity—Carmustine—melanoma	0.000113	0.0013	CcSEcCtD
Topotecan—Diarrhoea—Dactinomycin—melanoma	0.000112	0.00129	CcSEcCtD
Topotecan—Vomiting—Bleomycin—melanoma	0.000112	0.00128	CcSEcCtD
Topotecan—Anaemia—Docetaxel—melanoma	0.000112	0.00128	CcSEcCtD
Topotecan—Rash—Bleomycin—melanoma	0.000111	0.00127	CcSEcCtD
Topotecan—Dermatitis—Bleomycin—melanoma	0.000111	0.00127	CcSEcCtD
Topotecan—Asthenia—Carmustine—melanoma	0.00011	0.00126	CcSEcCtD
Topotecan—Hypersensitivity—Temozolomide—melanoma	0.000109	0.00125	CcSEcCtD
Topotecan—Leukopenia—Docetaxel—melanoma	0.000108	0.00124	CcSEcCtD
Topotecan—Asthenia—Temozolomide—melanoma	0.000107	0.00122	CcSEcCtD
Topotecan—Cough—Docetaxel—melanoma	0.000106	0.00121	CcSEcCtD
Topotecan—Diarrhoea—Carmustine—melanoma	0.000105	0.0012	CcSEcCtD
Topotecan—Pruritus—Temozolomide—melanoma	0.000105	0.0012	CcSEcCtD
Topotecan—Nausea—Bleomycin—melanoma	0.000105	0.0012	CcSEcCtD
Topotecan—Vomiting—Dactinomycin—melanoma	0.000104	0.00119	CcSEcCtD
Topotecan—Rash—Dactinomycin—melanoma	0.000104	0.00118	CcSEcCtD
Topotecan—Arthralgia—Docetaxel—melanoma	0.000103	0.00118	CcSEcCtD
Topotecan—Chest pain—Docetaxel—melanoma	0.000103	0.00118	CcSEcCtD
Topotecan—Myalgia—Docetaxel—melanoma	0.000103	0.00118	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000102	0.00117	CcSEcCtD
Topotecan—Dizziness—Carmustine—melanoma	0.000102	0.00116	CcSEcCtD
Topotecan—Diarrhoea—Temozolomide—melanoma	0.000102	0.00116	CcSEcCtD
Topotecan—Anaphylactic shock—Docetaxel—melanoma	9.88e-05	0.00113	CcSEcCtD
Topotecan—Dizziness—Temozolomide—melanoma	9.82e-05	0.00112	CcSEcCtD
Topotecan—Infection—Docetaxel—melanoma	9.81e-05	0.00112	CcSEcCtD
Topotecan—Vomiting—Carmustine—melanoma	9.77e-05	0.00112	CcSEcCtD
Topotecan—Nausea—Dactinomycin—melanoma	9.75e-05	0.00112	CcSEcCtD
Topotecan—Rash—Carmustine—melanoma	9.69e-05	0.00111	CcSEcCtD
Topotecan—Nervous system disorder—Docetaxel—melanoma	9.68e-05	0.00111	CcSEcCtD
Topotecan—Dermatitis—Carmustine—melanoma	9.68e-05	0.00111	CcSEcCtD
Topotecan—Thrombocytopenia—Docetaxel—melanoma	9.67e-05	0.00111	CcSEcCtD
Topotecan—Headache—Carmustine—melanoma	9.63e-05	0.0011	CcSEcCtD
Topotecan—Skin disorder—Docetaxel—melanoma	9.59e-05	0.0011	CcSEcCtD
Topotecan—Vomiting—Temozolomide—melanoma	9.44e-05	0.00108	CcSEcCtD
Topotecan—Anorexia—Docetaxel—melanoma	9.41e-05	0.00108	CcSEcCtD
Topotecan—Rash—Temozolomide—melanoma	9.36e-05	0.00107	CcSEcCtD
Topotecan—Dermatitis—Temozolomide—melanoma	9.35e-05	0.00107	CcSEcCtD
Topotecan—Headache—Temozolomide—melanoma	9.3e-05	0.00106	CcSEcCtD
Topotecan—Nausea—Carmustine—melanoma	9.13e-05	0.00104	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Docetaxel—melanoma	9e-05	0.00103	CcSEcCtD
Topotecan—Paraesthesia—Docetaxel—melanoma	8.87e-05	0.00101	CcSEcCtD
Topotecan—Nausea—Temozolomide—melanoma	8.82e-05	0.00101	CcSEcCtD
Topotecan—Dyspnoea—Docetaxel—melanoma	8.8e-05	0.00101	CcSEcCtD
Topotecan—Dyspepsia—Docetaxel—melanoma	8.69e-05	0.000995	CcSEcCtD
Topotecan—CYP3A4—Tamoxifen metabolism—CYP1B1—melanoma	8.6e-05	0.00312	CbGpPWpGaD
Topotecan—Decreased appetite—Docetaxel—melanoma	8.58e-05	0.000982	CcSEcCtD
Topotecan—Gastrointestinal disorder—Docetaxel—melanoma	8.53e-05	0.000975	CcSEcCtD
Topotecan—Fatigue—Docetaxel—melanoma	8.51e-05	0.000974	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—ABCB1—melanoma	8.51e-05	0.00309	CbGpPWpGaD
Topotecan—Pain—Docetaxel—melanoma	8.44e-05	0.000966	CcSEcCtD
Topotecan—Constipation—Docetaxel—melanoma	8.44e-05	0.000966	CcSEcCtD
Topotecan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—melanoma	8.39e-05	0.00304	CbGpPWpGaD
Topotecan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—melanoma	8.37e-05	0.00304	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—EDN1—melanoma	8.36e-05	0.00303	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	8.24e-05	0.00299	CbGpPWpGaD
Topotecan—Feeling abnormal—Docetaxel—melanoma	8.14e-05	0.000931	CcSEcCtD
Topotecan—Gastrointestinal pain—Docetaxel—melanoma	8.08e-05	0.000924	CcSEcCtD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—melanoma	8.03e-05	0.00291	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—melanoma	7.96e-05	0.00289	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—melanoma	7.92e-05	0.00287	CbGpPWpGaD
Topotecan—Abdominal pain—Docetaxel—melanoma	7.81e-05	0.000893	CcSEcCtD
Topotecan—Body temperature increased—Docetaxel—melanoma	7.81e-05	0.000893	CcSEcCtD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	7.81e-05	0.00283	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	7.8e-05	0.00283	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	7.79e-05	0.00282	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	7.58e-05	0.00275	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	7.42e-05	0.00269	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	7.42e-05	0.00269	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—TERT—melanoma	7.28e-05	0.00264	CbGpPWpGaD
Topotecan—Hypersensitivity—Docetaxel—melanoma	7.28e-05	0.000832	CcSEcCtD
Topotecan—ABCB1—Allograft Rejection—FOXP3—melanoma	7.23e-05	0.00262	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—ETS1—melanoma	7.18e-05	0.00261	CbGpPWpGaD
Topotecan—Asthenia—Docetaxel—melanoma	7.09e-05	0.000811	CcSEcCtD
Topotecan—CYP3A4—Irinotecan Pathway—APC—melanoma	7.07e-05	0.00256	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	7.06e-05	0.00256	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	7.01e-05	0.00254	CbGpPWpGaD
Topotecan—Pruritus—Docetaxel—melanoma	6.99e-05	0.000799	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—HIF1A—melanoma	6.96e-05	0.00253	CbGpPWpGaD
Topotecan—Diarrhoea—Docetaxel—melanoma	6.76e-05	0.000773	CcSEcCtD
Topotecan—Dizziness—Docetaxel—melanoma	6.53e-05	0.000747	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	6.44e-05	0.00233	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—NOS2—melanoma	6.33e-05	0.0023	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—EPO—melanoma	6.33e-05	0.00229	CbGpPWpGaD
Topotecan—Vomiting—Docetaxel—melanoma	6.28e-05	0.000718	CcSEcCtD
Topotecan—ABCG2—Transmembrane transport of small molecules—ARL2—melanoma	6.25e-05	0.00227	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—melanoma	6.24e-05	0.00226	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	6.23e-05	0.00226	CbGpPWpGaD
Topotecan—Rash—Docetaxel—melanoma	6.23e-05	0.000712	CcSEcCtD
Topotecan—Dermatitis—Docetaxel—melanoma	6.22e-05	0.000712	CcSEcCtD
Topotecan—Headache—Docetaxel—melanoma	6.19e-05	0.000708	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—TP53—melanoma	5.98e-05	0.00217	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—CXCR4—melanoma	5.89e-05	0.00214	CbGpPWpGaD
Topotecan—Nausea—Docetaxel—melanoma	5.87e-05	0.000671	CcSEcCtD
Topotecan—CYP3A4—Biological oxidations—UGT2B10—melanoma	5.7e-05	0.00207	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	5.64e-05	0.00205	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	5.6e-05	0.00203	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—IL6—melanoma	5.47e-05	0.00198	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	5.44e-05	0.00197	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—melanoma	5.43e-05	0.00197	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	5.26e-05	0.00191	CbGpPWpGaD
Topotecan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	5.06e-05	0.00183	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CTLA4—melanoma	4.97e-05	0.0018	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCB5—melanoma	4.88e-05	0.00177	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—TP53—melanoma	4.83e-05	0.00175	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	4.82e-05	0.00175	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	4.81e-05	0.00174	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC15A2—melanoma	4.74e-05	0.00172	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	4.6e-05	0.00167	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC17A5—melanoma	4.56e-05	0.00165	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	4.55e-05	0.00165	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—EDN1—melanoma	4.52e-05	0.00164	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	4.41e-05	0.0016	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	4.36e-05	0.00158	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	4.28e-05	0.00155	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	4.21e-05	0.00153	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC6A11—melanoma	4.14e-05	0.0015	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	4.05e-05	0.00147	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	4.05e-05	0.00147	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CD86—melanoma	3.94e-05	0.00143	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—TERT—melanoma	3.94e-05	0.00143	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL10—melanoma	3.87e-05	0.0014	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—HIF1A—melanoma	3.76e-05	0.00137	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL4—melanoma	3.76e-05	0.00136	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	3.74e-05	0.00136	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	3.72e-05	0.00135	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—PDGFRA—melanoma	3.7e-05	0.00134	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—HLA-B—melanoma	3.68e-05	0.00133	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—melanoma	3.67e-05	0.00133	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	3.67e-05	0.00133	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	3.63e-05	0.00132	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	3.63e-05	0.00131	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—FASLG—melanoma	3.6e-05	0.0013	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	3.58e-05	0.0013	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—FAS—melanoma	3.47e-05	0.00126	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	3.45e-05	0.00125	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	3.42e-05	0.00124	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—HLA-A—melanoma	3.41e-05	0.00124	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	3.38e-05	0.00123	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	3.35e-05	0.00122	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ACER3—melanoma	3.2e-05	0.00116	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	3.11e-05	0.00113	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	3.03e-05	0.0011	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	3.01e-05	0.00109	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—UGT2B10—melanoma	2.93e-05	0.00106	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CD80—melanoma	2.88e-05	0.00104	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HS3ST5—melanoma	2.72e-05	0.000987	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CASP8—melanoma	2.68e-05	0.00097	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	2.56e-05	0.000929	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	2.47e-05	0.000894	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—melanoma	2.34e-05	0.000849	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	2.32e-05	0.00084	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IFNG—melanoma	2.27e-05	0.000825	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	2.24e-05	0.000812	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—MDM2—melanoma	2.15e-05	0.000779	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CXCL8—melanoma	2.12e-05	0.000767	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PLCB4—melanoma	2.06e-05	0.000748	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CASP3—melanoma	2.02e-05	0.000734	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL2—melanoma	2.02e-05	0.000733	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	2.01e-05	0.00073	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	1.98e-05	0.000719	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIP4K2A—melanoma	1.94e-05	0.000703	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC6A11—melanoma	1.94e-05	0.000703	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP17A1—melanoma	1.9e-05	0.000689	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC5A5—melanoma	1.89e-05	0.000687	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	1.89e-05	0.000685	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTAP—melanoma	1.89e-05	0.000684	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	1.87e-05	0.00068	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	1.85e-05	0.00067	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	1.83e-05	0.000663	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	1.81e-05	0.000656	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	1.77e-05	0.000644	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	1.74e-05	0.000632	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ACER3—melanoma	1.73e-05	0.000628	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—VEGFA—melanoma	1.72e-05	0.000623	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	1.71e-05	0.000621	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PHGDH—melanoma	1.68e-05	0.00061	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LUM—melanoma	1.68e-05	0.00061	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	1.68e-05	0.000608	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HPSE—melanoma	1.65e-05	0.000598	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CUBN—melanoma	1.62e-05	0.000587	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP1B1—melanoma	1.6e-05	0.00058	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	1.59e-05	0.000578	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—UGT2B10—melanoma	1.58e-05	0.000574	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	1.58e-05	0.000572	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SDHD—melanoma	1.56e-05	0.000567	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—BSG—melanoma	1.56e-05	0.000567	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CSPG4—melanoma	1.56e-05	0.000567	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GPAM—melanoma	1.51e-05	0.000549	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	1.51e-05	0.000548	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	1.51e-05	0.000546	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TNF—melanoma	1.47e-05	0.000534	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HS3ST5—melanoma	1.47e-05	0.000534	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCB1—melanoma	1.44e-05	0.000524	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	1.42e-05	0.000514	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	1.4e-05	0.000508	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	1.32e-05	0.000479	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	1.3e-05	0.000471	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PLA2G6—melanoma	1.29e-05	0.000467	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	1.27e-05	0.000459	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	1.25e-05	0.000455	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	1.19e-05	0.000433	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—VCAN—melanoma	1.16e-05	0.000419	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	1.13e-05	0.000411	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	1.12e-05	0.000405	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PLCB4—melanoma	1.12e-05	0.000405	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	1.1e-05	0.000399	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	1.08e-05	0.00039	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ACER3—melanoma	1.07e-05	0.000387	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIP4K2A—melanoma	1.05e-05	0.00038	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC6A11—melanoma	1.05e-05	0.00038	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.02e-05	0.000371	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTAP—melanoma	1.02e-05	0.00037	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	1.02e-05	0.00037	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	9.99e-06	0.000362	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP17A1—melanoma	9.76e-06	0.000354	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—UGT2B10—melanoma	9.75e-06	0.000354	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	9.72e-06	0.000353	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	9.63e-06	0.000349	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	9.41e-06	0.000341	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	9.39e-06	0.00034	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	9.34e-06	0.000339	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GNA11—melanoma	9.22e-06	0.000334	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LUM—melanoma	9.09e-06	0.00033	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PHGDH—melanoma	9.09e-06	0.00033	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HS3ST5—melanoma	9.07e-06	0.000329	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ALB—melanoma	9.03e-06	0.000328	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—FASN—melanoma	9.02e-06	0.000327	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HPSE—melanoma	8.92e-06	0.000323	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC5A5—melanoma	8.87e-06	0.000322	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CUBN—melanoma	8.75e-06	0.000317	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GNAQ—melanoma	8.57e-06	0.000311	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CD44—melanoma	8.57e-06	0.000311	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	8.48e-06	0.000307	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SDHD—melanoma	8.45e-06	0.000307	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—BSG—melanoma	8.45e-06	0.000307	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CSPG4—melanoma	8.45e-06	0.000307	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP1B1—melanoma	8.21e-06	0.000298	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GPAM—melanoma	8.19e-06	0.000297	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	8.02e-06	0.000291	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	7.8e-06	0.000283	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	7.63e-06	0.000277	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	7.63e-06	0.000277	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	7.27e-06	0.000263	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	7.21e-06	0.000261	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PLA2G6—melanoma	6.96e-06	0.000252	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PLCB4—melanoma	6.87e-06	0.000249	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCB1—melanoma	6.76e-06	0.000245	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	6.62e-06	0.00024	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC6A11—melanoma	6.46e-06	0.000234	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIP4K2A—melanoma	6.46e-06	0.000234	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	6.41e-06	0.000232	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTAP—melanoma	6.29e-06	0.000228	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—VCAN—melanoma	6.25e-06	0.000227	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PRKCA—melanoma	6.22e-06	0.000226	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ERCC2—melanoma	6.17e-06	0.000224	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LUM—melanoma	5.6e-06	0.000203	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PHGDH—melanoma	5.6e-06	0.000203	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HPSE—melanoma	5.49e-06	0.000199	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	5.41e-06	0.000196	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CUBN—melanoma	5.39e-06	0.000196	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP17A1—melanoma	5.28e-06	0.000191	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SDHD—melanoma	5.21e-06	0.000189	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CSPG4—melanoma	5.21e-06	0.000189	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—BSG—melanoma	5.21e-06	0.000189	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GPAM—melanoma	5.04e-06	0.000183	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GNA11—melanoma	4.98e-06	0.000181	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	4.88e-06	0.000177	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CG—melanoma	4.88e-06	0.000177	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—FASN—melanoma	4.88e-06	0.000177	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC5A5—melanoma	4.8e-06	0.000174	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPARG—melanoma	4.71e-06	0.000171	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GNAQ—melanoma	4.63e-06	0.000168	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CD44—melanoma	4.63e-06	0.000168	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP1B1—melanoma	4.44e-06	0.000161	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PLA2G6—melanoma	4.29e-06	0.000156	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CD—melanoma	4.29e-06	0.000155	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALB—melanoma	4.23e-06	0.000153	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—VCAN—melanoma	3.85e-06	0.00014	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CB—melanoma	3.74e-06	0.000135	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—melanoma	3.7e-06	0.000134	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PRKCA—melanoma	3.37e-06	0.000122	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ERCC2—melanoma	3.34e-06	0.000121	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP17A1—melanoma	3.25e-06	0.000118	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTEN—melanoma	3.23e-06	0.000117	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GNA11—melanoma	3.07e-06	0.000111	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—FASN—melanoma	3e-06	0.000109	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC5A5—melanoma	2.95e-06	0.000107	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GNAQ—melanoma	2.85e-06	0.000103	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CD44—melanoma	2.85e-06	0.000103	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP1B1—melanoma	2.74e-06	9.92e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CG—melanoma	2.64e-06	9.56e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPARG—melanoma	2.54e-06	9.23e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CD—melanoma	2.32e-06	8.4e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALB—melanoma	2.29e-06	8.3e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CA—melanoma	2.28e-06	8.26e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCB1—melanoma	2.25e-06	8.17e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PRKCA—melanoma	2.07e-06	7.52e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ERCC2—melanoma	2.06e-06	7.46e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CB—melanoma	2.02e-06	7.33e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—melanoma	2e-06	7.26e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—melanoma	1.86e-06	6.75e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTEN—melanoma	1.75e-06	6.33e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CG—melanoma	1.62e-06	5.89e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPARG—melanoma	1.57e-06	5.68e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CD—melanoma	1.43e-06	5.18e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALB—melanoma	1.41e-06	5.11e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CB—melanoma	1.24e-06	4.51e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—melanoma	1.23e-06	4.47e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CA—melanoma	1.23e-06	4.47e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTEN—melanoma	1.08e-06	3.9e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—melanoma	1.01e-06	3.65e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CA—melanoma	7.59e-07	2.75e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—melanoma	6.2e-07	2.25e-05	CbGpPWpGaD
